Andrew Wagner
Overview
Explore the profile of Andrew Wagner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
407
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Olatoke T, Zhang E, Wagner A, He Q, Li S, Astreinidis A, et al.
bioRxiv
. 2024 Dec;
PMID: 39713456
Lymphangioleiomyomatosis (LAM) is a cystic lung disease that primarily affects women. LAM is caused by the invasion of metastatic smooth muscle-like cells into the lung parenchyma, leading to abnormal cell...
2.
Patel S, Patil D, Smith J, Saigal C, Litwin M, Hu J, et al.
JAMA Netw Open
. 2024 Oct;
7(10):e2440747.
PMID: 39446326
Importance: The association between radiotherapy (RT) timing after radical prostatectomy and long-term patient-reported health-related quality of life (HRQOL) in men with prostate cancer is unknown. Objective: To measure long-term HRQOL...
3.
Ernandez J, Kaul S, Fleishman A, Korets R, Chang P, Wagner A, et al.
Bladder Cancer
. 2024 Jul;
8(4):405-417.
PMID: 38994178
Background: Survival with locally advanced bladder cancer (LABC) following radical cystectomy (RC) remains poor. Although adjuvant chemotherapy (AC) is standard of care, one small, randomized trial has suggested a potential...
4.
Bang J, Arnoletti J, Wagner A, Varadarajulu S
Gut
. 2024 Apr;
74(1):e2.
PMID: 38609166
No abstract available.
5.
Desmond C, Kaul S, Fleishman A, Korets R, Chang P, Wagner A, et al.
Prostate Cancer Prostatic Dis
. 2024 Mar;
PMID: 38555410
Background: Although active surveillance is the preferred management for low-risk prostate cancer (PCa), some men remain at risk of overtreatment with definitive local therapy. We hypothesized that baseline characteristics may...
6.
Bang J, Arnoletti J, Wagner A, Varadarajulu S
Gut
. 2023 Dec;
73(3):395-397.
PMID: 38050116
No abstract available.
7.
Britt E, Qing X, Votava J, Lika J, Wagner A, Shen S, et al.
bioRxiv
. 2023 Oct;
PMID: 37808750
Neutrophils - the first responders in innate immunity - perform a variety of effector functions associated with specific metabolic demand. To maintain fitness and support functions, neutrophils have been found...
8.
Guo M, Morley M, Jiang C, Wu Y, Li G, Du Y, et al.
Nat Commun
. 2023 Jul;
14(1):4566.
PMID: 37516747
Accurate cell type identification is a key and rate-limiting step in single-cell data analysis. Single-cell references with comprehensive cell types, reproducible and functionally validated cell identities, and common nomenclatures are...
9.
Moreno M, Kaul S, Fleishman A, Korets R, Chang P, Wagner A, et al.
Urol Oncol
. 2023 Jul;
41(10):432.e11-432.e20.
PMID: 37500322
Introduction: Traditional surveillance protocols do not adequately account for the decreasing risk of mortality over time in aggressive malignancies, such as bladder cancer. Rather, the risk of death depends on...
10.
Olatoke T, Wagner A, Astrinidis A, Zhang E, Guo M, Zhang A, et al.
Sci Adv
. 2023 May;
9(19):eadf8549.
PMID: 37163604
Lymphangioleiomyomatosis (LAM) is a rare, progressive lung disease that predominantly affects women. LAM cells carry mutations, causing mTORC1 hyperactivation and uncontrolled cell growth. mTORC1 inhibitors stabilize lung function; however, sustained...